Innovative MedTech, Inc.
IMTH
$0.15
$0.0215.39%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -51.16% | -26.92% | -2.67% | 5.80% | 10.46% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -51.16% | -26.92% | -2.67% | 5.80% | 10.46% |
| Cost of Revenue | -66.80% | -81.34% | -87.00% | -87.96% | -67.56% |
| Gross Profit | 214.43% | 147.70% | 129.14% | 118.97% | 83.78% |
| SG&A Expenses | 259.91% | 509.91% | 317.31% | 263.24% | -91.56% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 108.39% | 99.36% | 23.97% | -4.45% | -87.15% |
| Operating Income | -162.80% | -196.26% | -72.87% | -15.18% | 90.64% |
| Income Before Tax | -332.61% | -385.06% | -204.14% | -114.80% | 90.07% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -332.61% | -385.06% | -204.14% | -114.80% | 90.07% |
| Earnings from Discontinued Operations | 113.11% | -3.26% | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -311.10% | -374.08% | -207.80% | -117.62% | 89.57% |
| EBIT | -162.80% | -196.26% | -72.87% | -15.18% | 90.64% |
| EBITDA | -169.73% | -204.17% | -74.89% | -14.89% | 90.94% |
| EPS Basic | -212.59% | -272.73% | -147.52% | -76.87% | 90.25% |
| Normalized Basic EPS | -92.67% | -141.03% | -45.85% | 1.48% | 90.68% |
| EPS Diluted | -208.91% | -259.94% | -141.35% | -73.45% | 90.19% |
| Normalized Diluted EPS | -92.67% | -141.03% | -45.85% | 1.48% | 90.68% |
| Average Basic Shares Outstanding | 63.66% | 26.40% | 14.90% | 7.14% | 1.92% |
| Average Diluted Shares Outstanding | 63.66% | 26.40% | 14.90% | 7.14% | 1.92% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |